Research into computer modelling for earlier DR detection

Article

A research initiative to develop new techniques for early detection of diabetic retinopathy (DR) is currently under way at the University of Lincoln, UK.

A research initiative to develop new techniques for early detection of diabetic retinopathy (DR) is currently under way at the University of Lincoln, UK.

DR is the most common cause of vision loss in individuals of working age, and estimates hold that in England, 4,200 individuals are at risk for blindness caused by DR each year, with 1,280 new cases identified annually.

Marie Curie Researcher Georgios Leontidis is currently investigating new methods for early screening and diagnosis of DR by developing computer models that can detect small changes in the blood vessels of the eye as part of the Retinal Vascular Modelling, Measurement and Diagnosis (REVAMMAD) project undertaken by researchers at the University of Lincoln, which has been awarded 900,000 euros by the European Union's 7th Framework (FP7) Marie Curie Initial Training Network program to lead the project.

An electronics and computer engineer, Georgios is investigating the effects of diabetes on the retina's vessel walls and how this could affect the flow of blood in the whole vasculature of the retina.

"Here at the University of Lincoln, our efforts focus on analysing images of diabetic patients before the first stage of diabetic retinopathy," said Georgios. "In that way we want to see what changes diabetes causes to the retina vessels and how these changes progress to retinopathy. We will then try to correlate the standard features we extract from these images with functional changes that occur, such as abnormality in blood pressure, blood flow volume and blood flow velocity, as well as to associate them with some risk factors like age, type of diabetes, duration of diabetes, gender and smoking," he added.

For more information on the REVAMMAD project, visit the project blog revammad.wordpress.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.